EVROF — Evrofarma SA Share Price
Last trade - 00:00- €22.29m
- €41.16m
- €48.76m
- 79
- 67
- 66
- 84
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.37 | ||
| Price to Tang. Book | 1.38 | ||
| Price to Free Cashflow | 32.49 | ||
| Price to Sales | 0.46 | ||
| EV to EBITDA | 7.16 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.78% | ||
| Return on Equity | 14.56% | ||
| Operating Margin | 8.29% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 33.48 | 33.91 | 36.7 | 45.38 | 48.76 | n/a | n/a | 8.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -10.69 | +8.71 | n/a | n/a | +60.53 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Evrofarma SA is a Greece-based company engaged in the production and trade of dairy products. The Company offers five ranges of products: Milk, including fresh whole, semi-skimmed and skimmed milk, highly pasteurized milk and chocolate flavored milk; the traditional Ariani Milk Drink, available also with added flavors; Yogurt, including traditional, cow-milk and strained yogurt; Milk Cream, as well as Cheese, such as goat, feta and organic feta cheese and anthotiro. It also supplies the yellow cheeses of Doiranis brand, including traditional kasseri and semi-hard cheeses. The Company’s milk supplies come from various farmers and associates in Macedonia and Thrace. Its production facilities cover 10,000 square meters and it has four distribution centers in Northern Greece, as well as a fleet of privately owned trucks that distribute its products in more than 3,000 points of sale locations. Evrofarma SA has a wholly owned subsidiary, Campus SA, which deals mainly with milk production.
Directors
- Athanasios Papazilakis CHM (57)
- Paschalis Papazilakis VCH (55)
- Nikolaos Mpozmpouazis CFO
- Dimitrios Giannoulakis EDR
- Anastasios Alexandridis NED (50)
- Panagiotis Theodoridis NED
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 17th, 1991
- Public Since
- June 12th, 2000
- No. of Employees
- 99
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Athens Exchange
- Shares in Issue
- 13,673,200
- Address
- 1st km Didimoticho - Orestiada, ALEXANDROUPOLI, 683 00
- Web
- https://www.evrofarma.gr/
- Phone
- +30 2553020020
- Contact
- Dimitrios Giannoulakis
- Auditors
- KSi Greece
Upcoming Events for EVROF
Similar to EVROF
Flour Mills C Sarantopoulos SA
Athens Exchange
Flour Mills Kepenos SA
Athens Exchange
Karelia Tobacco
Athens Exchange
Kreka SA
Athens Exchange
Kri Kri Milk Industry SA
Athens Exchange
FAQ
As of Today at 19:08 UTC, shares in Evrofarma SA are trading at €1.63. This share price information is delayed by 15 minutes.
Shares in Evrofarma SA last closed at €1.63 and the price had moved by +97.58% over the past 365 days. In terms of relative price strength the Evrofarma SA share price has outperformed the FTSE Global All Cap Index by +85.49% over the past year.
There is no consensus recommendation for this security.
Evrofarma SA does not currently pay a dividend.
Evrofarma SA does not currently pay a dividend.
Evrofarma SA does not currently pay a dividend.
To buy shares in Evrofarma SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €1.63, shares in Evrofarma SA had a market capitalisation of €22.29m.
Here are the trading details for Evrofarma SA:
- Country of listing: Greece
- Exchange: ATH
- Ticker Symbol: EVROF
Based on an overall assessment of its quality, value and momentum Evrofarma SA is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Evrofarma SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +53.28%.
As of the last closing price of €1.63, shares in Evrofarma SA were trading +35.84% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Evrofarma SA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €1.63.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Evrofarma SA's management team is headed by:
- Athanasios Papazilakis - CHM
- Paschalis Papazilakis - VCH
- Nikolaos Mpozmpouazis - CFO
- Dimitrios Giannoulakis - EDR
- Anastasios Alexandridis - NED
- Panagiotis Theodoridis - NED